My Quote Request
6505-01-482-9224
20 Products
NDC00074-5630-04
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014829224
NSN
6505-01-482-9224
NDC00074-5630-04
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014829224
NSN
6505-01-482-9224
MFG
ABBOTT LABORATORIES DIAGNOSTICS DIV PRICING D943 AP6C
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS OR INTRAVENOUS INFUSION OR INTRAMUSCULAR
FEATURES PROVIDED: DILUENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION USP 4ML 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT
SPECIAL FEATURES: ADD-VANTAGE DRUG DELIVERY SYSTEM; RECOMMENDED DILUENT IS BACTERIOSTATIC WATER FOR INJECTION, USP WITH 0.9% BENZYL ALCOHOL; SHOULD BE USED WITH 72 HOURS AFTER RECONSTITUTION AND STORED AT ROOM TEMPERATURE, 15 TO 30 DEG C; AVOID FREEZING; REFRIGERATION NOT
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: REQUIRED; 25 VIALS PER PKG
Related Searches:
00-0784
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
00-0784
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENTOLAMINE MESYLATE FOR INJECTION USP POWDER FORM 5MG VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS 5MG OF PHENTOLAMINE MESYLATE USP;25GM MANNITOL USP IN STERILE LYOPHILIZED FORM;FOR INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00083-6830-02
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
NDC00083-6830-02
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENTOLAMINE MESYLATE FOR INJECTION USP POWDER FORM 5MG VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS 5MG OF PHENTOLAMINE MESYLATE USP;25GM MANNITOL USP IN STERILE LYOPHILIZED FORM;FOR INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC55390-0113-01
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
NDC55390-0113-01
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENTOLAMINE MESYLATE FOR INJECTION USP POWDER FORM 5MG VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS 5MG OF PHENTOLAMINE MESYLATE USP;25GM MANNITOL USP IN STERILE LYOPHILIZED FORM;FOR INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
REGITINE
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
REGITINE
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENTOLAMINE MESYLATE FOR INJECTION USP POWDER FORM 5MG VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS 5MG OF PHENTOLAMINE MESYLATE USP;25GM MANNITOL USP IN STERILE LYOPHILIZED FORM;FOR INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
REGITINE MESYLATE FOR INJECTION
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
REGITINE MESYLATE FOR INJECTION
PHENTOLAMINE MESYLATE FOR INJECTION,USP
NSN, MFG P/N
6505014817003
NSN
6505-01-481-7003
MFG
CIBA-GEIGY CORP CIBA PHARMACEUTICALS DIV
Description
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENTOLAMINE MESYLATE FOR INJECTION USP POWDER FORM 5MG VIAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS 5MG OF PHENTOLAMINE MESYLATE USP;25GM MANNITOL USP IN STERILE LYOPHILIZED FORM;FOR INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
124L
CALCIUM FILM TABLET
NSN, MFG P/N
6505014817994
NSN
6505-01-481-7994
MFG
PHARMAVITE LLC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 500 ML STRENGTH; 30 COUNT
Related Searches:
T13813
CALCIUM FILM TABLET
NSN, MFG P/N
6505014817994
NSN
6505-01-481-7994
MFG
PHARMAVITE LLC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 500 ML STRENGTH; 30 COUNT
Related Searches:
01-0034
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505014821064
NSN
6505-01-482-1064
01-0034
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505014821064
NSN
6505-01-482-1064
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS KETOROLAC TROMETHAMINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML 1ML UNIT 10S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: NSAID; FOR MGMT OF MODERATELY SEVERE, ACUTE PAIN REQUIRING ANALGESIA AT OPOID LEVEL USUALLY IN POST OP SETTING THERAPY NOT TO EXCEED 5 DAYS; CARPUJET STERILE CARTRIDGE UNIT; LEUR LOCK; PKG 10
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00409-2287-31
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505014821064
NSN
6505-01-482-1064
NDC00409-2287-31
KETOROLAC TROMETHAMINE INJECTION,USP
NSN, MFG P/N
6505014821064
NSN
6505-01-482-1064
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS KETOROLAC TROMETHAMINE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE INJECTION USP 30MG/ML 1ML UNIT 10S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: NSAID; FOR MGMT OF MODERATELY SEVERE, ACUTE PAIN REQUIRING ANALGESIA AT OPOID LEVEL USUALLY IN POST OP SETTING THERAPY NOT TO EXCEED 5 DAYS; CARPUJET STERILE CARTRIDGE UNIT; LEUR LOCK; PKG 10
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC63653-1171-01
CLOPIDOGREL BISULFA
NSN, MFG P/N
6505014823067
NSN
6505-01-482-3067
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOPIDOGREL BISULFATE TABLETS 75MG EQUIVALANT 90S BT
SPECIAL FEATURES: 75 MG CLOPIDOGREL BISULFATE EQUIVALENT TO BASE; ORAL ADMINISTRATION; BOTTLE OF 90 TABLETS
Related Searches:
PLAVIX
CLOPIDOGREL BISULFA
NSN, MFG P/N
6505014823067
NSN
6505-01-482-3067
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOPIDOGREL BISULFATE TABLETS 75MG EQUIVALANT 90S BT
SPECIAL FEATURES: 75 MG CLOPIDOGREL BISULFATE EQUIVALENT TO BASE; ORAL ADMINISTRATION; BOTTLE OF 90 TABLETS
Related Searches:
01-0096
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505014824477
NSN
6505-01-482-4477
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN TABLETS USP 500MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 CAPLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STORE AT TEMPERATURE BETWEEN 59 AND 89 DEG F
Related Searches:
NDC17236-0607-10
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505014824477
NSN
6505-01-482-4477
NDC17236-0607-10
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505014824477
NSN
6505-01-482-4477
MFG
DIXON-SHANE LLC DBA R & S NORTHEAST
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN TABLETS USP 500MG 1000S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 CAPLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STORE AT TEMPERATURE BETWEEN 59 AND 89 DEG F
Related Searches:
005260202
BCG VACCINE,USP
NSN, MFG P/N
6505014828251
NSN
6505-01-482-8251
MFG
ORGANON INC ORGANON DIAGNOSTICS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TICE BCG
IMMEDIATE CONTAINER QUANTITY: 1
SPECIAL FEATURES: LIVE, ATTENUATED MYCOBACTERIA; STORAGE TEMPERATURE 36/46 DEGREES F; CONTAINS LIVE BACTERIA, PROTECT FROM DIRECT SUNLIGHT
Related Searches:
ONCOTICE
BCG VACCINE,USP
NSN, MFG P/N
6505014828251
NSN
6505-01-482-8251
MFG
ORGANON INC ORGANON DIAGNOSTICS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TICE BCG
IMMEDIATE CONTAINER QUANTITY: 1
SPECIAL FEATURES: LIVE, ATTENUATED MYCOBACTERIA; STORAGE TEMPERATURE 36/46 DEGREES F; CONTAINS LIVE BACTERIA, PROTECT FROM DIRECT SUNLIGHT
Related Searches:
NDC00168-0326-08
NITROGLYCERIN OINTMENT,USP
NSN, MFG P/N
6505014828822
NSN
6505-01-482-8822
NDC00168-0326-08
NITROGLYCERIN OINTMENT,USP
NSN, MFG P/N
6505014828822
NSN
6505-01-482-8822
MFG
VETERANS HEALTH
Description
ACTIVE INGREDIENT AND STRENGTH: 2.000 NITROGLYCERIN PERCENTAGE, W/V
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN OINTMENT USP 2% 1GM FOIL PACKS 48S
MEDICAMENT BASE TYPE: LANOLIN-PETROLATUM
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: STORE AT CONTROLLED ROOM TEMP 15 TO 30 DEG C; DISCARD FOILPAC IMMEDIATELY AFTER USE; SUPPLIED WITH A PAD OF RULED, IMPERMEABLE, PAPER APPLICATORS; 48 FOILPACS PER BOX
TOTAL PRIMARY CONTAINER QUANTITY: 48
USAGE DESIGN: FOR PREVENTION OF ANGINA PECTORIS DUE TO CORONARY ARTERY DISEASE
Related Searches:
NDC00281-0326-08
NITROGLYCERIN OINTMENT,USP
NSN, MFG P/N
6505014828822
NSN
6505-01-482-8822
NDC00281-0326-08
NITROGLYCERIN OINTMENT,USP
NSN, MFG P/N
6505014828822
NSN
6505-01-482-8822
MFG
SAVAGE LABORATORIES DIV OF ALTANA INC
Description
ACTIVE INGREDIENT AND STRENGTH: 2.000 NITROGLYCERIN PERCENTAGE, W/V
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN OINTMENT USP 2% 1GM FOIL PACKS 48S
MEDICAMENT BASE TYPE: LANOLIN-PETROLATUM
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: STORE AT CONTROLLED ROOM TEMP 15 TO 30 DEG C; DISCARD FOILPAC IMMEDIATELY AFTER USE; SUPPLIED WITH A PAD OF RULED, IMPERMEABLE, PAPER APPLICATORS; 48 FOILPACS PER BOX
TOTAL PRIMARY CONTAINER QUANTITY: 48
USAGE DESIGN: FOR PREVENTION OF ANGINA PECTORIS DUE TO CORONARY ARTERY DISEASE
Related Searches:
01-0098
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014829224
NSN
6505-01-482-9224
01-0098
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014829224
NSN
6505-01-482-9224
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS OR INTRAVENOUS INFUSION OR INTRAMUSCULAR
FEATURES PROVIDED: DILUENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION USP 4ML 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT
SPECIAL FEATURES: ADD-VANTAGE DRUG DELIVERY SYSTEM; RECOMMENDED DILUENT IS BACTERIOSTATIC WATER FOR INJECTION, USP WITH 0.9% BENZYL ALCOHOL; SHOULD BE USED WITH 72 HOURS AFTER RECONSTITUTION AND STORED AT ROOM TEMPERATURE, 15 TO 30 DEG C; AVOID FREEZING; REFRIGERATION NOT
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: REQUIRED; 25 VIALS PER PKG
Related Searches:
A-METHAPRED
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014829224
NSN
6505-01-482-9224
A-METHAPRED
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION,USP
NSN, MFG P/N
6505014829224
NSN
6505-01-482-9224
MFG
ABBOTT LABORATORIES DIAGNOSTICS DIV PRICING D943 AP6C
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS OR INTRAVENOUS INFUSION OR INTRAMUSCULAR
FEATURES PROVIDED: DILUENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION USP 4ML 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE, TWO COMPARTMENT
SPECIAL FEATURES: ADD-VANTAGE DRUG DELIVERY SYSTEM; RECOMMENDED DILUENT IS BACTERIOSTATIC WATER FOR INJECTION, USP WITH 0.9% BENZYL ALCOHOL; SHOULD BE USED WITH 72 HOURS AFTER RECONSTITUTION AND STORED AT ROOM TEMPERATURE, 15 TO 30 DEG C; AVOID FREEZING; REFRIGERATION NOT
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: REQUIRED; 25 VIALS PER PKG